Biogen Shares Rise After ‘Best-Case’ Alzheimer’s Drug Trial Results
On Wednesday, shares of Biogen (NASDAQ:BIIB) are trading sharply higher in pre-market as the company has announced positive topline results for its experimental Alzheimer’s drug....
Download Unicorn Signals App
Powered By EquityPandit
